NeuroOne Medical Technologies: A Step Forward in Neurological Disorders Treatment
On March 18, 2025, NeuroOne Medical Technologies Corporation made headlines as CEO Dave Rosa graced the screens of Today’s Marketplace (TMP), appearing alongside Dr. Jessica Clark, DNP, RN, Dean of the College of Nursing at Creighton University. The interview provided insight into NeuroOne’s innovative approach to improving surgical care and outcomes for patients suffering from neurological disorders.
NeuroOne Medical Technologies: The Company
NeuroOne Medical Technologies Corporation is a medical technology company dedicated to revolutionizing the treatment of neurological disorders. Based in Edina, Minnesota, NeuroOne’s mission is to develop and commercialize novel technologies that can enhance surgical procedures and improve patient outcomes. The company’s flagship product, the NeuroPort Neurostimulation System, is a prime example of their dedication to this goal.
The NeuroPort Neurostimulation System: A Game Changer
During the interview, Dave Rosa discussed NeuroOne’s groundbreaking NeuroPort Neurostimulation System. This innovative technology, which was FDA-cleared in 2022, uses real-time, intraoperative monitoring to optimize the placement of deep brain stimulation electrodes. This results in improved accuracy and safety during the surgical procedure.
Impact on Patients
For patients with neurological disorders such as Parkinson’s disease, essential tremor, or dystonia, the NeuroPort Neurostimulation System offers a significant improvement in their quality of life. The technology’s enhanced precision in electrode placement ensures that the therapeutic effects of deep brain stimulation are maximized, leading to better symptom control and overall improved patient outcomes.
- Reduced side effects
- Increased effectiveness of deep brain stimulation
- Improved accuracy during surgical procedures
- Enhanced patient safety
Impact on the World
The development and commercialization of the NeuroPort Neurostimulation System marks a significant step forward in the treatment of neurological disorders. By providing healthcare professionals with a more accurate and efficient deep brain stimulation procedure, NeuroOne Medical Technologies is not only improving the lives of individual patients but also contributing to a larger shift in the medical community.
- Advancement of minimally invasive procedures
- Reduction in healthcare costs related to incorrect electrode placements
- Increased accessibility to deep brain stimulation therapy
- Expansion of research opportunities in neurostimulation technology
Conclusion
NeuroOne Medical Technologies’ announcement of their NeuroPort Neurostimulation System’s feature on Today’s Marketplace is a testament to the company’s commitment to revolutionizing the treatment of neurological disorders. By providing healthcare professionals with a more accurate and efficient deep brain stimulation procedure, NeuroOne is not only improving the lives of individual patients but also contributing to a larger shift in the medical community. The impact of this technology on both patients and the world is significant, and we can expect to see continued advancements in neurostimulation technology as NeuroOne Medical Technologies continues to innovate.
Stay tuned for more updates on NeuroOne Medical Technologies and their groundbreaking work in neurological disorders treatment.
